Tom Caniels (@tomcaniels) header
Tom Caniels (@tomcaniels) profile picture

over on https://nitter.cf/t.co/HGWU1YmXdo

Amsterdam/Utrecht
Joined December 2009
Photo by Tom Caniels (@tomcaniels)Photo by Tom Caniels (@tomcaniels)Photo by Tom Caniels (@tomcaniels)Photo by Tom Caniels (@tomcaniels)Photo by Tom Caniels (@tomcaniels)Photo by Tom Caniels (@tomcaniels)Photo by Tom Caniels (@tomcaniels)Photo by Tom Caniels (@tomcaniels)Photo by Tom Caniels (@tomcaniels)Photo by Tom Caniels (@tomcaniels)
Getting a call from your PI: "hey, can you make some images detailing the Omicron variant for tonight?" Four hours later, on national TV @Nieuwsuur:
28
142
16
1,468
Excited to share that the peer-reviewed version of our paper is out today!! Congrats to everyone that contributed to this wonderful story led by @adonisrubio99 🤩 Bispecific antibodies targeting the N-terminal and receptor binding domains | science.org/doi/10.1126/scit…
2
12
2
87
4,497
A little overdue, but in August we shared work on our HIV vaccine candidate in @SciImmunology! This vaccine is now in clinical trials... more on that (hopefully) soon 🤞 😄 What did we do...? ⬇️ buff.ly/4gxyqVi
1
2
182
4. We are not there yet - bnAbs are still the holy grail for HIV vaccines, and we likely need more booster immunogens that mimic the high complexity of HIV itself.
1
1
56
A huge thank you to the Ward (@WardLab1) and Wilson labs (Scripps), the Batista lab (Ragon) and our collaborators all over. This work has led to a clinical trial (buff.ly/4jHBMaH), which we're incredibly excited about. First results: soon! 🔜
45
What an amazing story that was such a blast to collaborate on with @mfgrp lab!!! Phenomenal work led by @DjenetBousbaine and all co-authors!! Unroll this thread and be amazed 🤯👇🏾
Today we report that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent antibody response against a pathogen. Could lead to topical vaccines that are applied in a cream. @DjenetBousbaine led the charge... @Nature 1/55
2
6
1
36
9,115
I have a PhD position open in my lab. Looking for glyco and viro enthusiasts who love science! Sharing is caring ;) @E_A_Karlsson @UU_Glycoscience #glycotime uu.nl/en/organisation/workin…
18
23
3,075
Truly groundbreaking - biannual administration of injectable pre-exposure prophylaxis in this phase 3 trial, ✨𝒛𝒆𝒓𝒐✨ HIV infections. #AIDS2024
In the PURPOSE 1 randomized, controlled trial involving women in South Africa & Uganda, twice-yearly subcutaneous lenacapavir was superior to daily oral emtricitabine–tenofovir disoproxil fumarate in preventing HIV infection. Full trial results: nej.md/3zRElVj #AIDS2024
1
5
591
Tom Caniels retweeted
A 60-year-old man in Germany has become at least the seventh person with HIV to be announced free of the virus after receiving a stem-cell transplant go.nature.com/3yf3fOg
29
488
47
1,354
89,612